Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Addict Behav. 2009 Apr 2;34(8):649–653. doi: 10.1016/j.addbeh.2009.03.037

Table 2.

Logistic regression analysis: Predictors of illicit use of pharmaceutical opioids in past 30 days.

Variable Odds ratio 95% CI p value
Age 0.95 0.85 – 1.07 0.402
Male (vs. female ) 1.34 0.77 – 2.33 0.299
Ethnicity (vs. White)
 African American 0.31 0.10 – 1.01 0.052
 Other ethnicity 1.33 0.52 – 3.41 0.549
School enrollment (vs. not in school) 0.75 0.41 – 1.37 0.345
Treatment history (vs. never in treatment) 0.83 0.43 – 1.63 0.591
Depressive symptoms (BDI scores ‘≥20’ vs. ‘<20’) 2.15 1.04 – 4.44 0.039
Marijuana use past 30 days (vs. 0 days)
 > 20 days 2.07 0.84 – 5.12 0.114
 1–20 days 1.54 0.60 – 3.95 0.365
Drunk past 30 days (vs. 0 days)
 10 or more days 1.32 0.55 – 3.12 0.535
 1–9 days 0.89 0.40 – 1.97 0.766
Other drug use past 30 days (vs. no use)
 Heroin 2.22 0.53 – 9.24 0.275
 Cocaine 1.48 0.80 – 2.70 0.210
 Methamphetamine 0.71 0.29 – 1.71 0.440
 Ketamine 0.75 0.34 – 1.66 0.472
 Prescription tranquilizers 6.43 3.36 – 12.31 <0.001
 Prescription stimulants 2.90 1.33 – 6.32 0.007
 LSD and psilocybin 2.02 1.03 – 3.94 0.040
 Inhalants 2.26 1.01 - 5.06 0.048
Lifetime MDMA use (vs. 1–10 occasions)
 > 50 occasions 0.77 0.33 – 1.82 0.551
 21–50 occasions 1.95 0.96 – 3.97 0.065
 11–20 occasions 1.20 0.59 – 2.43 0.617

Hosmer-Lemeshow Test: X2 =5.42, df=8, p=0.712